Financhill
Back

Entrada Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Buy
65

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-34.62%
Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
21.47
Seasonality Move:
4.48%
Buy
65
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.80. The Score for TRDA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.48. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.48
    The current trend is relatively stagnant and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 57.68 Buy
Chaikin Money Flow: 68474 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.1 - 19.1) Buy
Bollinger Bands (100): (15.08 - 17.94) Buy

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 48.92 Sell
Chaikin Money Flow: 621365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.03 - 22.71) Sell
Bollinger Bands (100): (17.61 - 21.71) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.36 Buy
20-day SMA: 18.36 Buy
50-day SMA: 17.01 Buy
200-day SMA: 15.21 Buy
8-day EMA: 18.37 Buy
20-day EMA: 18.21 Buy
50-day EMA: 17.42 Buy
200-day EMA: 15.87 Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.38 Buy
20-day SMA: 22 Sell
50-day SMA: 21.11 Buy
200-day SMA: 17.57 Buy
8-day EMA: 21.5 Sell
20-day EMA: 21.67 Sell
50-day EMA: 21.07 Buy
200-day EMA: 18.25 Buy

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):